Загрузка...
In silico molecular docking analysis for repurposing approved antiviral drugs against SARS-CoV-2 main protease
Developing a safe and effective antiviral treatment takes a decade, however, when it comes to the coronavirus disease (COVID-19), time is a sensitive matter to slow the spread of the pandemic. Screening approved antiviral drugs against COVID-19 would speed the process of finding therapeutic treatmen...
Сохранить в:
| Опубликовано в: : | Biochem Biophys Rep |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8173495/ https://ncbi.nlm.nih.gov/pubmed/34099985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrep.2021.101032 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|